4//SEC Filing
RIEFLIN WILLIAM JL 4
Accession 0001415889-25-013719
CIK 0001806952other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 6:48 PM ET
Size
5.8 KB
Accession
0001415889-25-013719
Insider Transaction Report
Form 4
RIEFLIN WILLIAM JL
Director
Transactions
- Award
Option (right to buy)
2025-05-15+130,000→ 130,000 totalExercise: $0.40Exp: 2035-05-14→ Common Stock (130,000 underlying)
Footnotes (1)
- [F1]The option shares shall vest on the earlier of (a) the date of the next annual meeting of the stockholders that occurs following May 15, 2025 (or the date immediately prior to such date if the Reporting Person's service as a director ends at such annual meeting due to the Reporting Person's failure to be reelected or the Reporting Person not standing for re-election); or (b) the first anniversary of May 15, 2025, subject to the Reporting Person providing continuous service through such date.
Documents
Issuer
Lyell Immunopharma, Inc.
CIK 0001806952
Entity typeother
Related Parties
1- filerCIK 0001182471
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 6:48 PM ET
- Size
- 5.8 KB